Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.09 USD | -5.22% | +0.93% | +98.18% |
05-14 | Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+98.18% | 42.44M | |
+65.25% | 62.59B | |
-1.27% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.34% | 26.21B | |
-21.77% | 19.09B | |
+4.92% | 13.08B | |
+25.53% | 12.26B | |
+28.61% | 12.05B |
- Stock Market
- Equities
- XLO Stock
- News Xilio Therapeutics, Inc.
- Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022